BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn's disease. Dis Mon. 2018;64:20-57. [PMID: 28826742 DOI: 10.1016/j.disamonth.2017.07.001] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 21.6] [Reference Citation Analysis]
Number Citing Articles
1 Schwartzberg DM, Remzi FH. The Role of Laparoscopic, Robotic, and Open Surgery in Uncomplicated and Complicated Inflammatory Bowel Disease.Gastrointest Endosc Clin N Am. 2019;29:563-576. [PMID: 31078253 DOI: 10.1016/j.giec.2019.02.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Alagón Fernández Del Campo P, De Orta Pando A, Straface JI, López Vega JR, Toledo Plata D, Niezen Lugo SF, Alvarez Hernández D, Barrientos Fortes T, Gutiérrez-Kobeh L, Solano-Gálvez SG, Vázquez-López R. The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Med Sci (Basel) 2019;7:E33. [PMID: 30813381 DOI: 10.3390/medsci7020033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Törüner M, Akpınar H, Akyüz F, Dağlı Ü, Över Hamzaoğlu H, Tezel A, Ünsal B, Yıldırım S, Çelik AF. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management. Turk J Gastroenterol 2019;30:S913-46. [PMID: 32207688 DOI: 10.5152/tjg.2019.061119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Jang EJ, Ha JE, Im SG, Kim MG, Sohn HS. A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease. Clin Drug Investig 2019;39:625-30. [DOI: 10.1007/s40261-019-00784-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ghoshal UC, Yadav A, Fatima B, Agrahari AP, Misra A. Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study. Indian J Gastroenterol 2021. [PMID: 34390471 DOI: 10.1007/s12664-021-01211-6] [Reference Citation Analysis]
6 Yan W, Meihao W, Zihan S, Lingjie H, Haotian C, Qian C, Lianli S. Correlation Between Crohn Disease Activity and Serum Selenium Concentration. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.03.005] [Reference Citation Analysis]
7 Pimentel AM, Rocha R, Santana GO. Crohn’s disease of esophagus, stomach and duodenum. World J Gastrointest Pharmacol Ther 2019; 10(2): 35-49 [PMID: 30891327 DOI: 10.4292/wjgpt.v10.i2.35] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
8 Schineis C, Ullrich A, Lehmann KS, Holmer C, Lauscher JC, Weixler B, Kreis ME, Seifarth C. Microscopic inflammation in ileocecal specimen does not correspond to a higher anastomotic leakage rate after ileocecal resection in Crohn's disease. PLoS One 2021;16:e0247796. [PMID: 33661983 DOI: 10.1371/journal.pone.0247796] [Reference Citation Analysis]
9 Liang L, Lin R, Xie Y, Lin H, Shao F, Rui W, Chen H. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer. Int J Biol Sci 2021;17:2548-60. [PMID: 34326693 DOI: 10.7150/ijbs.58671] [Reference Citation Analysis]
10 Dreja J, Ekberg O, Leander P, Månsson S, Ohlsson B. Volumetric analysis of small bowel motility in an unselected cohort of patients with Crohn's disease. Neurogastroenterol Motil 2020;32:e13909. [PMID: 32469111 DOI: 10.1111/nmo.13909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhao J, Liao D, Wilkens R, Krogh K, Glerup H, Gregersen H. Bowel stiffness associated with histopathologic scoring of stenosis in patients with Crohn's disease. Acta Biomater 2021;130:332-42. [PMID: 34119715 DOI: 10.1016/j.actbio.2021.06.011] [Reference Citation Analysis]
12 Sudhakar P, Verstockt B, Cremer J, Verstockt S, Sabino J, Ferrante M, Vermeire S. Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis. Inflamm Bowel Dis 2021;27:870-86. [PMID: 33313682 DOI: 10.1093/ibd/izaa281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Manceur AM, Ding Z, Muser E, Obando C, Voelker J, Pilon D, Kinkead F, Lafeuille MH, Lefebvre P. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs. J Med Econ 2020;23:1092-101. [PMID: 32609019 DOI: 10.1080/13696998.2020.1789649] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Bottoms L, Leighton D, Carpenter R, Anderson S, Langmead L, Ramage J, Faulkner J, Coleman E, Fairhurst C, Seed M, Tew G. Affective and enjoyment responses to 12 weeks of high intensity interval training and moderate continuous training in adults with Crohn's disease. PLoS One 2019;14:e0222060. [PMID: 31539378 DOI: 10.1371/journal.pone.0222060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chiarello MM, Pepe G, Fico V, Bianchi V, Tropeano G, Altieri G, Brisinda G. Therapeutic strategies in Crohn’s disease in an emergency surgical setting. World J Gastroenterol 2022; 28(18): 1902-1921 [DOI: 10.3748/wjg.v28.i18.1902] [Reference Citation Analysis]
16 Zhang J, Huang Q, Zhao R, Ma Z. A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn's disease. BMC Complement Med Ther 2020;20:95. [PMID: 32293395 DOI: 10.1186/s12906-020-02885-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Hossein-Khannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, Kadri N, Vosough M. Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results. Hum Cell 2021;34:1289-300. [PMID: 34057700 DOI: 10.1007/s13577-021-00560-w] [Reference Citation Analysis]
18 Ray G, Longworth MS. Epigenetics, DNA Organization, and Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:235-47. [PMID: 30407525 DOI: 10.1093/ibd/izy330] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
19 Peñate Medina T, Kolb JP, Hüttmann G, Huber R, Peñate Medina O, Ha L, Ulloa P, Larsen N, Ferrari A, Rafecas M, Ellrichmann M, Pravdivtseva MS, Anikeeva M, Humbert J, Both M, Hundt JE, Hövener JB. Imaging Inflammation - From Whole Body Imaging to Cellular Resolution. Front Immunol 2021;12:692222. [PMID: 34248987 DOI: 10.3389/fimmu.2021.692222] [Reference Citation Analysis]
20 Azimirad M, Tajbakhsh M, Yadegar A, Zali MR. Recurrent urinary tract infection with antibiotic-resistant Klebsiella pneumoniae in a patient with Crohn's disease: A case report. Clin Case Rep 2021;9:e04531. [PMID: 34401151 DOI: 10.1002/ccr3.4531] [Reference Citation Analysis]
21 Magombedze G, Marino S. Mathematical and computational approaches in understanding the immunobiology of granulomatous diseases. Current Opinion in Systems Biology 2018;12:1-11. [DOI: 10.1016/j.coisb.2018.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Rankala R, Mattila K, Voutilainen M, Mustonen A. Inflammatory bowel disease-related economic costs due to presenteeism and absenteeism. Scand J Gastroenterol 2021;56:687-92. [PMID: 33826877 DOI: 10.1080/00365521.2021.1908416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lazou A, Ikonomidis I, Bartekova M, Benedek T, Makavos G, Palioura D, Cabrera Fuentes H, Andreadou I. Chronic inflammatory diseases, myocardial function and cardioprotection. Br J Pharmacol 2020;177:5357-74. [PMID: 31943142 DOI: 10.1111/bph.14975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
24 Pak SJ, Kim YI, Yoon YS, Lee JL, Lee JB, Yu CS. Short-term and long-term outcomes of laparoscopic vs open ileocolic resection in patients with Crohn's disease: Propensity-score matching analysis. World J Gastroenterol 2021; 27(41): 7159-7172 [PMID: 34887635 DOI: 10.3748/wjg.v27.i41.7159] [Reference Citation Analysis]
25 Mainoli B, Hirota S, Edgington-mitchell LE, Lu C, Dufour A. Proteomics and Imaging in Crohn’s Disease: TAILS of Unlikely Allies. Trends in Pharmacological Sciences 2020;41:74-84. [DOI: 10.1016/j.tips.2019.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Müller S. Non-infectious Granulomatous Lesions of the Orofacial Region. Head Neck Pathol 2019;13:449-56. [PMID: 30627963 DOI: 10.1007/s12105-018-00997-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
27 Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019;2019:7247238. [PMID: 31886308 DOI: 10.1155/2019/7247238] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 31.7] [Reference Citation Analysis]
28 Yao Q, Li E, Shen B. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity 2019;52:48-56. [PMID: 31084224 DOI: 10.1080/08916934.2019.1613382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Vargas-Robles H, Castro-Ochoa KF, Citalán-Madrid AF, Schnoor M. Beneficial effects of nutritional supplements on intestinal epithelial barrier functions in experimental colitis models in vivoWorld J Gastroenterol 2019; 25(30): 4181-4198 [PMID: 31435172 DOI: 10.3748/wjg.v25.i30.4181] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
30 Liu F, Li D, Wang X, Cui Y, Li X. Polyphenols intervention is an effective strategy to ameliorate inflammatory bowel disease: a systematic review and meta-analysis. Int J Food Sci Nutr 2021;72:14-25. [PMID: 32369394 DOI: 10.1080/09637486.2020.1760220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Wu Y, Shen J. Innate Lymphoid Cells in Crohn's Disease. Front Immunol 2020;11:554880. [PMID: 33329513 DOI: 10.3389/fimmu.2020.554880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Eugenicos MP, Ferreira NB. Psychological factors associated with inflammatory bowel disease. Br Med Bull 2021;138:16-28. [PMID: 34057462 DOI: 10.1093/bmb/ldab010] [Reference Citation Analysis]
33 Singh SK, Basu S. An invited commentary on "Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn's disease patients with normal BMI: A cohort study. International Journal of Surgery 2020. doi:10.1016/j.ijsu.2020.05.064". Int J Surg 2020;80:91-2. [PMID: 32652293 DOI: 10.1016/j.ijsu.2020.06.042] [Reference Citation Analysis]
34 Villanacci V, Reggiani-Bonetti L, Caprioli F, Saragoni L, Salviato T, Mescoli C, Canavese G, Manenti S, Spada E, Baron L, Leoncini G, Cadei M, Battista S, Armuzzi A. Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC). Dig Liver Dis 2020;52:262-7. [PMID: 31884010 DOI: 10.1016/j.dld.2019.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Williams WV, Brind J, Haynes L, Manhart MD, Klaus H, Lanfranchi A, Migeon G, Gaskins M, Šeman EI, Ruppersberger L, Raviele KM. Hormonally Active Contraceptives, Part II: Sociological, Environmental, and Economic Impact. Linacre Q 2021;88:291-316. [PMID: 34565905 DOI: 10.1177/00243639211005121] [Reference Citation Analysis]
36 Khoshnevisan R, Nekooei-Marnany N, Klein C, Kotlarz D, Behnam M, Ostadi V, Yaran M, Rezaei A, Sherkat R. IL-12Rβ1 deficiency corresponding to concurrency of two diseases, mendelian susceptibility to mycobacterial disease and Crohn's disease. J Clin Tuberc Other Mycobact Dis 2019;17:100123. [PMID: 31788565 DOI: 10.1016/j.jctube.2019.100123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Chang HC, Chen G, Chung HW, Wu PY, Liang L, Juan CJ, Liu YJ, Tse MD, Chan A, Zhang S, Chiu KW. Multi-shot Diffusion-Weighted MRI With Multiplexed Sensitivity Encoding (MUSE) in the Assessment of Active Inflammation in Crohn's Disease. J Magn Reson Imaging 2021. [PMID: 34169600 DOI: 10.1002/jmri.27801] [Reference Citation Analysis]
38 Olaisen M, Flatberg A, Granlund AVB, Røyset ES, Martinsen TC, Sandvik AK, Fossmark R. Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease. Inflamm Bowel Dis 2021;27:12-24. [PMID: 32448900 DOI: 10.1093/ibd/izaa107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
39 Hernandez-Nieto C, Sekhon L, Lee J, Gounko D, Copperman A, Sandler B. Infertile patients with inflammatory bowel disease have comparable in vitro fertilization clinical outcomes to the general infertile population. Gynecol Endocrinol 2020;36:554-7. [PMID: 31691606 DOI: 10.1080/09513590.2019.1684465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
40 Lee B, Elston DM. The uses of naltrexone in dermatologic conditions. Journal of the American Academy of Dermatology 2019;80:1746-52. [DOI: 10.1016/j.jaad.2018.12.031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
41 Garza-hernandez D, Estrada K, Trevino V. Multivariate genome-wide association study models to improve prediction of Crohn’s disease risk and identification of potential novel variants. Computers in Biology and Medicine 2022;145:105398. [DOI: 10.1016/j.compbiomed.2022.105398] [Reference Citation Analysis]
42 Zou Y, Liu S, Wu J, Sun Z. Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature. World J Surg Oncol 2021;19:332. [PMID: 34809643 DOI: 10.1186/s12957-021-02443-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Mu X, Fardy J, Reid S, Trahey J. Severe drug-associated colitis with Crohn's features in setting of ixekizumab therapy for chronic plaque psoriasis. BMC Gastroenterol 2021;21:361. [PMID: 34600483 DOI: 10.1186/s12876-021-01936-w] [Reference Citation Analysis]
44 Revilla L, Mayorgas A, Corraliza AM, Masamunt MC, Metwaly A, Haller D, Tristán E, Carrasco A, Esteve M, Panés J, Ricart E, Lozano JJ, Salas A. Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis. PLoS One 2021;16:e0246367. [PMID: 33556098 DOI: 10.1371/journal.pone.0246367] [Reference Citation Analysis]
45 Alawi F, Shields BE, Omolehinwa T, Rosenbach M. Oral Granulomatous Disease. Dermatol Clin 2020;38:429-39. [PMID: 32892852 DOI: 10.1016/j.det.2020.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Mulinari Turin de Oliveira N, Barbosa da Luz B, Schneider VS, Barbosa da Costa Filho H, Sérgio de Araujo Sousa P, Fernanda de Paula Werner M, Henrique Loiola Ponte de Souza M, Almeida Rocha J, Antonio Duarte Nicolau L, Mach Côrtes Cordeiro L, Maria-ferreira D. Dietary polysaccharides from guavira pomace, a co-product from the fruit pulp industry, display therapeutic application in gut disorders. Food Research International 2022;156:111291. [DOI: 10.1016/j.foodres.2022.111291] [Reference Citation Analysis]
47 Dunne MR, Byrne G, Chirdo FG, Feighery C. Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder. Front Immunol 2020;11:1374. [PMID: 32733456 DOI: 10.3389/fimmu.2020.01374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
48 Knights AJ, Yang L, Shah M, Norton LJ, Green GS, Stout ES, Vohralik EJ, Crossley M, Quinlan KGR. Krüppel-like factor 3 (KLF3) suppresses NF-κB-driven inflammation in mice. J Biol Chem 2020;295:6080-91. [PMID: 32213596 DOI: 10.1074/jbc.RA120.013114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ju JK, Cho YN, Park KJ, Kwak HD, Jin HM, Park SY, Kim HS, Kee SJ, Park YW. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease. J Innate Immun 2020;12:422-34. [PMID: 32535589 DOI: 10.1159/000507931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
50 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Reference Citation Analysis]
51 Kopiasz Ł, Dziendzikowska K, Gajewska M, Oczkowski M, Majchrzak-Kuligowska K, Królikowski T, Gromadzka-Ostrowska J. Effects of Dietary Oat Beta-Glucans on Colon Apoptosis and Autophagy through TLRs and Dectin-1 Signaling Pathways-Crohn's Disease Model Study. Nutrients 2021;13:321. [PMID: 33499397 DOI: 10.3390/nu13020321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Taguchi N, Oda S, Kobayashi T, Naoe H, Sasaki Y, Imuta M, Nakaura T, Yamashita Y. Advanced parametric imaging for evaluation of Crohn's disease using dual-energy computed tomography enterography. Radiol Case Rep 2018;13:709-12. [PMID: 30050596 DOI: 10.1016/j.radcr.2018.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Haddad A, Ben Mahmoud A, Chaker Y, Zehani A, Ksantini R, Kacem MJ. Presentation with perforation of the terminal ileum and acute limb ischemia in Crohn's disease: A case report. Int J Surg Case Rep 2021;80:105626. [PMID: 33601328 DOI: 10.1016/j.ijscr.2021.02.012] [Reference Citation Analysis]
54 Månsson S, Ekberg O, Ohlsson B. Motility index measured by magnetic resonance enterography is associated with sex and mural thickness. World J Gastroenterol 2020; 26(36): 5484-5497 [PMID: 33024399 DOI: 10.3748/wjg.v26.i36.5484] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Park CJ, Chen W, Pirasteh A, Kim DH, Perlman SB, Robbins JB, McMillan AB. Initial Experience With Low-Dose 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging With Deep Learning Enhancement. J Comput Assist Tomogr 2021. [PMID: 34176877 DOI: 10.1097/RCT.0000000000001174] [Reference Citation Analysis]
56 O'Brien KJ, Parisi X, Shelman NR, Merideth MA, Introne WJ, Heller T, Gahl WA, Malicdan MCV, Gochuico BR. Inflammatory bowel disease in Hermansky-Pudlak syndrome: a retrospective single-centre cohort study. J Intern Med 2021;290:129-40. [PMID: 33423334 DOI: 10.1111/joim.13224] [Reference Citation Analysis]
57 Yasueda A, Sekido Y, Takeda T, Ogino T, Miyoshi N, Takahashi H, Uemura M, Doki Y, Eguchi H, Mizushima T. Sarcopenia hinders the decline in disease activity after surgery for people with Crohn's disease: Preliminary results. Nutrition 2021;94:111526. [PMID: 34861460 DOI: 10.1016/j.nut.2021.111526] [Reference Citation Analysis]
58 Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, Ziade N, Hashash JG. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65:100851. [PMID: 30837080 DOI: 10.1016/j.disamonth.2019.02.004] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 16.7] [Reference Citation Analysis]
59 Irak K, Bayram M, Cifci S, Sener G. Serum levels of NLRC4 and MCP-2/CCL8 in patients with active Crohn's disease. PLoS One 2021;16:e0260034. [PMID: 34788319 DOI: 10.1371/journal.pone.0260034] [Reference Citation Analysis]
60 Piotrowska M, Binienda A, Fichna J. The role of fatty acids in Crohn's disease pathophysiology - An overview. Mol Cell Endocrinol 2021;538:111448. [PMID: 34480991 DOI: 10.1016/j.mce.2021.111448] [Reference Citation Analysis]
61 Gómez-Escudero O, Remes-Troche JM. Approach to the adult patient with chronic diarrhea: a literature review. Rev Gastroenterol Mex 2021:S0375-0906(21)00038-0. [PMID: 34074557 DOI: 10.1016/j.rgmx.2021.02.002] [Reference Citation Analysis]
62 Ho SL, Niu F, Pola S, Velayos FS, Ning X, Hui RL. Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort Study. BioDrugs 2020;34:395-404. [PMID: 32103457 DOI: 10.1007/s40259-020-00409-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
63 Woelke S, Valesky E, Bakhtiar S, Pommerening H, Pfeffermann LM, Schubert R, Zielen S. Treatment of Granulomas in Patients With Ataxia Telangiectasia. Front Immunol 2018;9:2000. [PMID: 30279689 DOI: 10.3389/fimmu.2018.02000] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
64 Libera J, Iłowiecka K, Stasiak D. Consumption of processed red meat and its impact on human health: A review. Int J of Food Sci Tech 2021;56:6115-23. [DOI: 10.1111/ijfs.15270] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Clark R, Johnson R. Malabsorption Syndromes. Nurs Clin North Am 2018;53:361-74. [PMID: 30100002 DOI: 10.1016/j.cnur.2018.05.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
66 Ali AK, Torosian A, Porter C, Bloomfeld RS, Feldman SR. New onset inflammatory bowel disease in patient treated with secukinumab: Case report and review of literature. Dermatol Ther 2021;:e15151. [PMID: 34609037 DOI: 10.1111/dth.15151] [Reference Citation Analysis]
67 Pellino G, Keller DS, Sampietro GM, Annese V, Carvello M, Celentano V, Coco C, Colombo F, Cracco N, Di Candido F, Franceschi M, Laureti S, Mattioli G, Pio L, Sciaudone G, Sica G, Villanacci V, Zinicola R, Leone S, Danese S, Spinelli A, Delaini G, Selvaggi F;  the Italian Society of Colorectal Surgery (SICCR). Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management. Tech Coloproctol. 2020;24:105-126. [PMID: 31983044 DOI: 10.1007/s10151-019-02145-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
68 Atherly T, Rossi G, White R, Seo YJ, Wang C, Ackermann M, Breuer M, Allenspach K, Mochel JP, Jergens AE. Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease. PLoS One 2019;14:e0226780. [PMID: 31887117 DOI: 10.1371/journal.pone.0226780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
69 Georgopoulos I, Mavrigiannaki E, Stasinopoulou S, Renieris G, Nikolakis G, Bamias G, Tiniakos D, Papaconstantinou I. Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice. Dig Dis Sci 2021. [PMID: 34350516 DOI: 10.1007/s10620-021-07161-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Garza-Hernandez D, Sepulveda-Villegas M, Garcia-Pelaez J, Aguirre-Gamboa R, Lakatos PL, Estrada K, Martinez-Vazquez M, Trevino V. A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes. BMC Genomics 2022;23:302. [PMID: 35418025 DOI: 10.1186/s12864-022-08491-y] [Reference Citation Analysis]
71 Chen H, Xu H, Luo L, Qiao L, Wang Y, Xu M, Li Y, Zhu P, Yang B. Thalidomide Prevented and Ameliorated Pathogenesis of Crohn's Disease in Mice via Regulation of Inflammatory Response and Fibrosis. Front Pharmacol 2019;10:1486. [PMID: 31920668 DOI: 10.3389/fphar.2019.01486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Oliveira MC, Elias JB, Moraes DA, Simões BP, Rodrigues M, Ribeiro AAF, Piron-Ruiz L, Ruiz MA, Hamerschlak N. A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation. Hematol Transfus Cell Ther 2021;43:65-86. [PMID: 32418777 DOI: 10.1016/j.htct.2020.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
73 Wang X, Xie L, Long J, Liu K, Lu J, Liang Y, Cao Y, Dai X, Li X. Therapeutic effect of baicalin on inflammatory bowel disease: A review. J Ethnopharmacol 2022;283:114749. [PMID: 34666140 DOI: 10.1016/j.jep.2021.114749] [Reference Citation Analysis]
74 Mégier C, Bourbao-Tournois C, Perrotin F, Merle P, Ouaissi M, Diguisto C. Long-term evaluation of the impact of delivery modalities on anal continence in women with Crohn's disease. J Visc Surg 2021:S1878-7886(21)00129-6. [PMID: 34799288 DOI: 10.1016/j.jviscsurg.2021.08.002] [Reference Citation Analysis]
75 Zbroja M, Cyranka W, Kuczyńska M, Brodzisz A, Maria Woźniak M. Perianal lesions as an unusual first manifestation of Crohn's disease in pediatric patients - case series. J Ultrason 2020;20:e222-5. [PMID: 33365161 DOI: 10.15557/JoU.2020.0038] [Reference Citation Analysis]
76 Balbas-martinez V, Asin-prieto E, Parra-guillen ZP, Troconiz IF. A Quantitative Systems Pharmacology Model for the Key Interleukins Involved in Crohn's Disease. J Pharmacol Exp Ther 2020;372:299-307. [DOI: 10.1124/jpet.119.260539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
77 Belyayev L, Hawksworth J, Khan K, Kaufman S, Subramanian S, Kroemer A, Loh K, Girlanda R, Fishbein TM, Matsumoto CS. Immunologic Complications and Graft Survival in Crohn's Disease and NOD2 Mutant Non-Crohn's Disease Adult Recipients Following Intestine Transplantation. Transplant Direct 2020;6:e556. [PMID: 32607422 DOI: 10.1097/TXD.0000000000001006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Cui Y, Lu SY, Xu J, Peng YS, Miao Q, Wang XQ, Chen XY, Ran ZH. Microscopic features of small bowel mucosa of patients with Crohn's disease. BMC Gastroenterol 2019;19:232. [PMID: 31888502 DOI: 10.1186/s12876-019-1138-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
79 Papalia I, Tjandra D, Quah S, Tan C, Gorelik A, Sivanesan S, Macrae F. Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease. Inflamm Bowel Dis 2021;27:S25-32. [PMID: 34791289 DOI: 10.1093/ibd/izab180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Makaro A, Fichna J, Włodarczyk M. Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products. Curr Drug Targets 2020;21:1456-62. [PMID: 32718287 DOI: 10.2174/1389450121666200727105218] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hadid B, Buehring W, Mannino A, Weisberg MD, Golub IJ, Ng MK, Razi AE. Crohn's Disease Increases In-Hospital Lengths of Stay, Medical Complications, and Costs of Care following Primary Total Knee Arthroplasty. J Knee Surg 2021. [PMID: 34794196 DOI: 10.1055/s-0041-1739199] [Reference Citation Analysis]
82 Stephens M, von der Weid P. Lymphatic pumping and pathological consequences of its dysfunction. Lymphatic Structure and Function in Health and Disease. Elsevier; 2020. pp. 19-54. [DOI: 10.1016/b978-0-12-815645-2.00003-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Li H, Mo Y, Huang C, Ren Q, Xia X, Nan X, Shuai X, Meng X. An MSCT-based radiomics nomogram combined with clinical factors can identify Crohn's disease and ulcerative colitis. Ann Transl Med 2021;9:572. [PMID: 33987270 DOI: 10.21037/atm-21-1023] [Reference Citation Analysis]
84 Shahinfar H, Payandeh N, ElhamKia M, Abbasi F, Alaghi A, Djafari F, Eslahi M, Gohari NSF, Ghorbaninejad P, Hasanzadeh M, Jafari A, Jibril AT, Khorasaniha R, Mansouri E, Monfared V, Rezaee S, Salehian A, Shahavandi M, Sheikhi L, Milajerdi A. Administration of dietary antioxidants for patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled clinical trials. Complement Ther Med 2021;63:102787. [PMID: 34751147 DOI: 10.1016/j.ctim.2021.102787] [Reference Citation Analysis]
85 Hashash JG, Fadel CGA, Rimmani HH, Sharara AI. Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn's disease and ulcerative colitis. Ann Gastroenterol 2021;34:612-24. [PMID: 34475731 DOI: 10.20524/aog.2021.0645] [Reference Citation Analysis]
86 Bao L, Zhao J, Liao D, Wang G, Gregersen H. Pressure overload changes mesenteric afferent nerve responses in a stress-dependent way in a fasting rat model. Biomech Model Mechanobiol 2020;19:1741-53. [PMID: 32072371 DOI: 10.1007/s10237-020-01305-8] [Reference Citation Analysis]
87 Stankovic B, Dragasevic S, Klaassen K, Kotur N, Srzentic Drazilov S, Zukic B, Sokic Milutinovic A, Milovanovic T, Lukic S, Popovic D, Pavlovic S, Nikcevic G. Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy. Pathol Res Pract 2020;216:152945. [PMID: 32279918 DOI: 10.1016/j.prp.2020.152945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Front Immunol 2020;11:2144. [PMID: 33042125 DOI: 10.3389/fimmu.2020.02144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
89 Detz DJ, Podrat JL, Muniz Castro JC, Lee YK, Zheng F, Purnell S, Pei KY. Small bowel obstruction. Curr Probl Surg 2021;58:100893. [PMID: 34130796 DOI: 10.1016/j.cpsurg.2020.100893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Dionizio A, Uyghurturk DA, Melo CGS, Sabino-Arias IT, Araujo TT, Ventura TMS, Perles JVCM, Zanoni JN, Den Besten P, Buzalaf MAR. Intestinal changes associated with fluoride exposure in rats: Integrative morphological, proteomic and microbiome analyses. Chemosphere 2021;273:129607. [PMID: 33508686 DOI: 10.1016/j.chemosphere.2021.129607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Kwak MS, Cha JM, Shin HP, Jeon JW, Yoon JY. Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn's Disease. Front Microbiol 2020;11:1162. [PMID: 32582102 DOI: 10.3389/fmicb.2020.01162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Lin R, Lin W, Wang C, Dong J, Zheng W, Zeng D, Liu Y, Lin C, Jiao Z, Huang P. Population pharmacokinetics of azathioprine active metabolite in patients with inflammatory bowel disease and dosage regimens optimisation. Basic Clin Pharmacol Toxicol 2021;128:482-92. [PMID: 33150655 DOI: 10.1111/bcpt.13530] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Huldani H, Margiana R, Ahmad F, Opulencia MJC, Ansari MJ, Bokov DO, Abdullaeva NN, Siahmansouri H. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells. International Immunopharmacology 2022;107:108698. [DOI: 10.1016/j.intimp.2022.108698] [Reference Citation Analysis]
94 Alula KM, Jackson DN, Smith AD, Kim DS, Turner K, Odstrcil E, Kaipparettu BA, Dassopoulos T, Venuprasad K, Feagins LA, Theiss AL. Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn's Disease. Cells 2021;10:1349. [PMID: 34072441 DOI: 10.3390/cells10061349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Gómez-Escudero O, Remes-Troche JM. Approach to the adult patient with chronic diarrhea: A literature review. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00087-6. [PMID: 34389290 DOI: 10.1016/j.rgmxen.2021.08.007] [Reference Citation Analysis]
96 Ingallinella S, Campanelli M, Antonelli A, Arcudi C, Bellato V, Divizia A, Franceschilli M, Petagna L, Sensi B, Sibio S, Siragusa L, Sica GS. The Role of Active Inflammation and Surgical Therapy in Crohn's Disease Recurrence. Gastroenterol Res Pract 2020;2020:2845407. [PMID: 33456458 DOI: 10.1155/2020/2845407] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Ma L, Li W, Zhuang N, Yang H, Liu W, Zhou W, Jiang Y, Li J, Zhu Q, Qian J. Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn's disease. Therap Adv Gastroenterol 2021;14:17562848211016259. [PMID: 34178114 DOI: 10.1177/17562848211016259] [Reference Citation Analysis]
98 Dragasevic S, Stankovic B, Sokic-Milutinovic A, Milosavljevic T, Milovanovic T, Lukic S, Drazilov SS, Klaassen K, Kotur N, Pavlovic S, Popovic D. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study. Clin Immunol 2018;197:86-95. [PMID: 30193869 DOI: 10.1016/j.clim.2018.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
99 Santiago M, Dias CC, Alves C, Ministro P, Gonçalves R, Carvalho D, Portela F, Correia L, Lago P, Magro F. The Magnitude of Crohn's Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review. Inflamm Bowel Dis 2022:izab334. [PMID: 35179190 DOI: 10.1093/ibd/izab334] [Reference Citation Analysis]
100 Berwick DC, Heaton GR, Azeggagh S, Harvey K. LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same. Mol Neurodegener 2019;14:49. [PMID: 31864390 DOI: 10.1186/s13024-019-0344-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 14.7] [Reference Citation Analysis]
101 Raffner Basson A, Gomez-Nguyen A, LaSalla A, Buttó L, Kulpins D, Warner A, Di Martino L, Ponzani G, Osme A, Rodriguez-Palacios A, Cominelli F. Replacing Animal Protein with Soy-Pea Protein in an "American Diet" Controls Murine Crohn Disease-Like Ileitis Regardless of Firmicutes: Bacteroidetes Ratio. J Nutr 2021;151:579-90. [PMID: 33484150 DOI: 10.1093/jn/nxaa386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
102 Artym J, Kocięba M, Zaczyńska E, Zimecki M, Kałas W, Strządała L, Pawlak A, Jeleń M, Morak-Młodawska B, Pluta K, Kaleta-Kuratewicz K, Madej JP, Kuropka P, Kuryszko J. Therapeutic effects of an azaphenothiazine derivative in mouse experimental colitis. Histol Histopathol 2020;35:691-9. [PMID: 31833559 DOI: 10.14670/HH-18-192] [Reference Citation Analysis]
103 Zhang J, Wang XJ, Wu LJ, Yang L, Yang YT, Zhang D, Hong J, Li XY, Dong XQ, Guo XC, Han R, Ma X. Herb-partitioned moxibustion alleviates colonic inflammation in Crohn's disease rats by inhibiting hyperactivation of the NLRP3 inflammasome via regulation of the P2X7R-Pannexin-1 signaling pathway. PLoS One 2021;16:e0252334. [PMID: 34043726 DOI: 10.1371/journal.pone.0252334] [Reference Citation Analysis]
104 Wilson BC, Vatanen T, Cutfield WS, O'Sullivan JM. The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Front Cell Infect Microbiol. 2019;9:2. [PMID: 30719428 DOI: 10.3389/fcimb.2019.00002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 39.0] [Reference Citation Analysis]
105 Malesza IJ, Malesza M, Krela-Kaźmierczak I, Zielińska A, Souto EB, Dobrowolska A, Eder P. Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults. Int J Mol Sci 2020;21:E5223. [PMID: 32718006 DOI: 10.3390/ijms21155223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
106 Ariyoshi T, Hagihara M, Eguchi S, Fukuda A, Iwasaki K, Oka K, Takahashi M, Yamagishi Y, Mikamo H. Clostridium butyricum MIYAIRI 588-Induced Protectin D1 Has an Anti-inflammatory Effect on Antibiotic-Induced Intestinal Disorder. Front Microbiol 2020;11:587725. [PMID: 33193245 DOI: 10.3389/fmicb.2020.587725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
107 Limanskiy V, Vyas A, Chaturvedi LS, Vyas D. Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease. World J Gastroenterol 2019; 25(18): 2177-2187 [PMID: 31143069 DOI: 10.3748/wjg.v25.i18.2177] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
108 M’koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina 2022;58:567. [DOI: 10.3390/medicina58050567] [Reference Citation Analysis]
109 Fedor I, Zold E, Barta Z. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease. J Clin Med 2021;10:5984. [PMID: 34945280 DOI: 10.3390/jcm10245984] [Reference Citation Analysis]
110 Ali AS, Alhothali OS, Hammoudah AA, Kh Alsaede A, Alraddadi AA. Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion. Case Rep Gastroenterol 2021;15:626-31. [PMID: 34616267 DOI: 10.1159/000515611] [Reference Citation Analysis]
111 Wang R, Graham S, Sun N, McCarthy D, Peng R, Erickson J, Oconnor L, Zhu X, Wurbel M, Dunstan R, Westmoreland S, Chung N, Ghayur T, Gu J. CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40. PLoS One 2020;15:e0228221. [PMID: 32155151 DOI: 10.1371/journal.pone.0228221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Lin SN, Zheng DP, Qiu Y, Zhang SH, He Y, Chen BL, Zeng ZR, Mao R, Chen MH. Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification. Therap Adv Gastroenterol 2020;13:1756284820968732. [PMID: 33329758 DOI: 10.1177/1756284820968732] [Reference Citation Analysis]
113 Takač B, Mihaljević S, Glavaš-Obrovac L, Kibel A, Suver-Stević M, Canecki-Varžić S, Samardžija M, Rajkovac I, Kovač D, Štefanić M. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS. Acta Clin Croat 2020;59:67-80. [PMID: 32724277 DOI: 10.20471/acc.2020.59.01.09] [Reference Citation Analysis]
114 Ellis K, Munro D, Clarke J. Endometriosis Is Undervalued: A Call to Action. Front Glob Womens Health 2022;3:902371. [DOI: 10.3389/fgwh.2022.902371] [Reference Citation Analysis]
115 Pham DT, Tetyczka C, Hartl S, Absenger-novak M, Fröhlich E, Tiyaboonchai W, Roblegg E. Comprehensive investigations of fibroin and poly(ethylenimine) functionalized fibroin nanoparticles for ulcerative colitis treatment. Journal of Drug Delivery Science and Technology 2020;57:101484. [DOI: 10.1016/j.jddst.2019.101484] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
116 Shero N, Pandeya DR. Impact of Crohn's disease during pregnancy on children with attention deficit hyperactivity disorder: A review. Annals of Medicine and Surgery 2022;75:103369. [DOI: 10.1016/j.amsu.2022.103369] [Reference Citation Analysis]